Resapp Health Ltd (RAP)

Sydney
0.041
-0.002(-4.65%)
  • Volume:
    2,668,914
  • Bid/Ask:
    0.041/0.042
  • Day's Range:
    0.041 - 0.043

RAP Overview

Prev. Close
0.043
Day's Range
0.041-0.043
Revenue
90K
Open
0.043
52 wk Range
0.04-0.155
EPS
-0.01
Volume
2,668,914
Market Cap
31.08M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,041,963
P/E Ratio
-
Beta
0.11
1-Year Change
-69.63%
Shares Outstanding
758,119,489
Next Earnings Date
29 Aug 2021
What is your sentiment on Resapp Health Ltd?
or
Vote to see community's results!

Resapp Health Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Resapp Health Ltd Company Profile

Resapp Health Ltd Company Profile

Employees
500
Market
Australia

ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department, and primary care markets; and SleepCheck, a direct-to-consumer smartphone application for the self-assessment of sleep apnoea in 36 countries. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. ResApp Health Limited has a joint development and pilot agreement with Medgate AG to integrate and test smartphone-based acute respiratory diagnostic test. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.